Paola Valeria Marchese
Overview
Explore the profile of Paola Valeria Marchese including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
104
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Broseghini E, Veronesi G, Gardini A, Venturi F, Scotti B, Vespi L, et al.
Arch Dermatol Res
. 2024 Dec;
317(1):78.
PMID: 39643819
Since melanoma incidence is steadily increasing, guidelines regarding the diagnosis, staging, and treatment of melanoma are constantly being updated. In particular, the use of adjuvant therapy in stage IIb/c melanoma...
2.
De Giglio A, Leonetti A, Comito F, Filippini D, Mollica V, Rihawi K, et al.
Cancer Immunol Immunother
. 2024 Oct;
73(12):246.
PMID: 39358642
Background: Immune checkpoint inhibitors (ICIs) are standard treatments for advanced solid cancers. Resistance to ICIs, both primary and secondary, poses challenges, with early mortality (EM) within 30-90 days indicating a...
3.
Saoudi Gonzalez N, Marchese P, Baraibar I, Ros J, Salva F, Rodriguez M, et al.
Expert Opin Investig Drugs
. 2024 May;
33(6):613-625.
PMID: 38775361
Introduction: The global prevalence of colorectal cancer highlights the need to enhance treatment strategies for improved patient outcomes. The pivotal role of epidermal growth factor receptor (EGFR) signaling in regulating...
4.
Maloberti T, De Leo A, Coluccelli S, Sanza V, Gruppioni E, Altimari A, et al.
Diagnostics (Basel)
. 2024 Apr;
14(8).
PMID: 38667446
Cutaneous melanoma is one of the most lethal tumors among skin cancers, characterized by complex genetic and molecular alterations that result in uncontrolled cell proliferation and metastatic spread. Next-generation sequencing...
5.
Filippini D, Abeshi A, Tober N, Marchese P, Andrini E, Lamberti G, et al.
AME Case Rep
. 2024 Jan;
8:21.
PMID: 38234336
Background: Laryngeal neuroendocrine tumors (NETs) represent less than 1% of all malignancies originating from the larynx and available data are limited on case reports. Calcitonin secreting laryngeal NETs are extremely...
6.
Mollica V, Tassinari E, Santoni M, Marchese P, Giunchi F, Maloberti T, et al.
Pathol Res Pract
. 2023 Dec;
253:155008.
PMID: 38103361
Background: TERT promoter mutation is one of the most common genomic alterations in urothelial carcinoma (UC). Its prognostic role on patients' outcomes is still not clear. Methods: We performed a...
7.
Tateo V, Marchese P, Mollica V, Massari F, Kurzrock R, Adashek J
Pharmaceuticals (Basel)
. 2023 Apr;
16(4).
PMID: 37111371
(1) Background: The oncology field has drastically changed with the advent of precision medicine, led by the discovery of druggable genes or immune targets assessed through next-generation sequencing. Biomarker-based treatments...
8.
Nigro M, Marchese P, Deiana C, Casadio C, Galvani L, Di Federico A, et al.
Lung Cancer (Auckl)
. 2023 Feb;
14:11-25.
PMID: 36762267
Precision medicine has revolutionized the therapeutic management of cancer patients with a major impact on non-small cell lung cancer (NSCLC), particularly lung adenocarcinoma, where advances have been remarkable. Tissue biopsy,...
9.
Marchese P, Mollica V, Tassinari E, de Biase D, Giunchi F, Marchetti A, et al.
Expert Rev Mol Diagn
. 2022 Dec;
22(11):997-1008.
PMID: 36503370
Introduction: The reactivation of telomerase represents a key moment in the carcinogenesis process. Mutations in the central promoter region of the telomerase reverse transcriptase (TERT) gene cause telomerase reactivation in...
10.
Marchese P, Mollica V, de Biase D, Giunchi F, Tassinari E, Marchetti A, et al.
Pathol Res Pract
. 2022 Jun;
236:153983.
PMID: 35751929
Background: The therapeutic scenario of urothelial carcinoma is constantly expanding with the widening of the knowledge on molecular characteristics, thus claiming for the need of prognostic and predictive factors to...